Augmentin Dosing for UTI
Augmentin (amoxicillin/clavulanate) is not a first-line agent for uncomplicated UTIs in adults or children, and current guidelines do not recommend it for this indication due to better alternatives with proven efficacy and lower resistance concerns. 1, 2
Why Augmentin Is Not Recommended for UTI
The most recent 2024 guidelines explicitly prioritize other agents for UTI treatment:
- For uncomplicated cystitis: Nitrofurantoin is the drug of choice, with TMP/SMX or pivmecillinam as alternatives 1
- For pyelonephritis: Fluoroquinolones, TMP/SMX, or first-generation cephalosporins are preferred 1, 2
- Beta-lactams (including Augmentin): Guidelines state there is "not enough evidence to provide a clear recommendation for duration of treatment" for cystitis, indicating insufficient data to support their use 1
The 2024 European Association of Urology guidelines make no mention of amoxicillin/clavulanate as a recommended option for either uncomplicated cystitis or pyelonephritis 2.
If Augmentin Must Be Used (Non-Guideline Supported)
Adults
The FDA label does not provide specific UTI dosing. Historical literature suggests:
- Standard dosing: 500 mg/125 mg three times daily or 875 mg/125 mg twice daily 3, 4
- Duration: 5-7 days based on older studies 5, 3
- Success rates: Only ~70% for amoxicillin-resistant organisms 3
Pediatric Patients (≥3 months)
Based on FDA labeling for other indications 6:
- Standard formulation: 20-40 mg/kg/day (amoxicillin component) divided every 8-12 hours
- ES-600 formulation: 90 mg/kg/day divided every 12 hours (maximum dose based on amoxicillin component) 6
- Duration: 10 days based on pediatric studies 7, 5
Renal Dose Adjustment
The FDA label recommends:
- CrCl 10-30 mL/min: Standard dose every 12 hours
- CrCl <10 mL/min: Standard dose every 24 hours
- Hemodialysis: Additional dose during and after dialysis
Critical Caveats
Do not use Augmentin if better alternatives are available. The 2024 guidelines emphasize antimicrobial stewardship, and beta-lactams should be reserved for infections where they demonstrate clear superiority 1.
For UTIs specifically:
- Nitrofurantoin achieves superior urinary concentrations and has better resistance profiles 1
- Augmentin has higher rates of gastrointestinal side effects (diarrhea 8-12%) compared to first-line agents 8
- Increasing E. coli resistance to amoxicillin (>67% in some studies) limits utility 7
If a beta-lactam is absolutely required, consider cephalosporins (cefpodoxime, ceftibuten) which have established UTI dosing regimens and guideline support 2.